Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial by Sylvain A. Lother, Wen Teng, Olawale Ayilara, Brett L. Houston, Barret Rush, Srinivas Murthy, Jose C. Nicolau, Lindsay Bond, Alexis F. Turgeon, John C. Marshall, Jonathan Paul, Judith S. Hochman, Matthew D. Neal, Michael E. Farkouh, Joel Nkosi, Donald S. Houston, Charlotte A. Bradbury, Asher A. Mendelson, Ewan C. Goligher, Allan Garland, Robert Balshaw, Souradet Y. Shaw, Patrick R. Lawler, Yoav Keynan, Ryan Zarychanski

Get full text

Impact of Apolipoprotein A-I Infusions on Cardiovascular Events Post-MI by Neutrophil-Lymphocyte Ratio and LDL-Cholesterol Levels by Sem A.O.F. Rikken, MD, C. Michael Gibson, MD, MS, M. Cecilia Bahit, MD, Danielle Duffy, MD, Gerald Chi, MD, Serge Korjian, MD, Niekbachsh Mohammadnia, MD, Harvey White, DSc, Gaya Anschuetz, MS, Bronwyn A. Kingwell, PhD, Ton Oude Ophuis, MD, PhD, Jose C. Nicolau, MD, PhD, Renato D. Lopes, MD, PhD, Basil S. Lewis, MD, Saloua El Messaoudi, MD, PhD, Dragos Vinereanu, MD, PhD, Jurriën M. ten Berg, MD, PhD, Shaun G. Goodman, MD, MSc, Christoph Bode, MD, PhD, P. Gabriel Steg, MD, Peter Libby, MD, Kevin R. Bainey, MD, Arnoud W.J. van 't Hof, MD, PhD, Paul M. Ridker, MD, Kenneth W. Mahaffey, MD, Stephen J. Nicholls, MD, Roxana Mehran, MD, Robert A. Harrington, MD, Jan H. Cornel, MD, PhD

Get full text